Dr. Pavan Tummala, MD

Dr. Tummala practices at Cox Medical Center South in Springfield, Missouri, part of Lester E. Cox Medical Centers.

Dr. Tummala's NPI, 1407111313, was assigned on July 6, 2012. Dr. Tummala holds Georgia license 96271.

Dr. Tummala's primary practice is Cox Medical Center South, at 3801 South National Avenue, Springfield, MO 65807 in Greene County. The practice phone is (417) 269-6000.

Dr. Tummala's primary practice is Cox Medical Center South in Springfield, Missouri, part of Lester E. Cox Medical Centers. Dr. Tummala is also affiliated with Northeast Georgia Medical Center Gainesville. The medical group on file is Northeast Georgia Physicians Group Inpatient Neurology. Dmand AI also links Dr. Tummala to 4 more hospitals, 4 medical groups, 2 group practices and clinics and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tummala practices, 9 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Tummala's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dmand AI has Dr. Tummala's licenses on file in 2 states: Georgia and Missouri.

CMS data shows 810 Medicare services from Dr. Tummala across 14 procedure codes in 2024, for 533 Medicare patients. Medicare paid $73,053 for them.

CMS counts 533 Medicare patients who saw Dr. Tummala in 2024. The largest group is 65 to 74, with 221 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.64, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Tummala's median patient age at 72, with 55% women.

In 2024, Dr. Tummala wrote 2,502 Medicare Part D claims for 531 patients. 92% of them were for generic drugs. CMS names the drug for 2,221 of them, across 44 drugs with 11 or more claims each, at $136,249 in total drug cost. In 2023, CMS named 6,463 claims across 73 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Tummala for performance year 2024, reported through an alternative payment model (APM). Dr. Tummala accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Tummala as offering telehealth.

CMS Open Payments shows 649 general payments to Dr. Tummala from 74 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 98% of the total. Abbvie Inc. paid the most, $1,862.